Altimmune Inc
(STU:3G0)
€
2.455
-0.060 (-2.39%)
Market Cap: 479.87 Mil
Enterprise Value: 220.21 Mil
PE Ratio: 0
PB Ratio: 1.29
GF Score: 34/100 Altimmune Inc at JMP Securities Life Sciences Conference Transcript
Jun 16, 2022 / 01:00PM GMT
Release Date Price:
€6.89
(-9.99%)
Jon Wolleben
JMP Securities LLC - Analyst
Thanks for coming out on a wet morning. My name is Jon Wolleben, senior analyst here at JMP Securities. And Altimmune is a company we have been covering for quite some time that's seeing a lot of excitement in the obesity space. So we are pleased to have CEO, Vipin Garg; and Chief Medical Officer, Scott Harris joining us today. Thanks for making it out today, guys.
Scott Harris
Altimmune, Inc. - Chief Medical Officer
Sure.
Vipin Garg
Altimmune, Inc. - President & CEO
Yes, absolutely. Our pleasure. Thank you for inviting us.
Questions & Answers
Jon Wolleben
JMP Securities LLC - Analyst
And maybe, Vipin, to start, some people may not be as familiar with Altimmune. Can you give a little bit about the history of the company and your focus today?
Vipin Garg
Altimmune, Inc. - President & CEO
Yeah, sure. So as you mentioned, we are working in the obesity space. We have
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot